Neurolept Anesthesia
An antipsychotic agent such as droperidol plus an opiate analgesic agent such as fentanyl or sufentanil. This latter agent is approximately eight to ten times more potent than fentanyl.

CHOLINERGIC DRUGS

Produce actions similar to Acetylcholine (Ach)

Cholinergic Agonists
1 Acetylcholine  2 Methacholine  3. Carbachol 4 Bethnechol

Alkaloids
1.Muscarine 2 Pilocarpine 3. Arecoline

MECHANISM OF ACTION
I Heart- hyperpolarizes the SA node and decreases the rate of diastolic depolarisation. thus the frequcncy of impulse generation is decreased. bradycardia.
2 Blood vessels- vasodilatation
3. Smooth muscles - increased contraction. increased tone. increased peristalsis.
4. Glands- increased sweating. increased lacrimation.
5 Eye- contraction of the circular muscle of iris (miosis).

Nicotinic action
Autonomic ganglia - stimu1ation of sympathetic and parasympathetic system.
Skeletalmuscles - contraction of fibres.
CNS..No effect as it does not penetrate the blood-brain barrier.

Toxic effects
Flushing. sweating.salivation. cramps. belching. involuntary mictuirition. defaccation.

Contraindication
1.. Anginapectoris- decreases the coronary flow.
2 Pepticulcer - increases the gastric secretion
3 Asthma- bronchoconstriction
4 Hyperthyroidisim

Cholinomimetic Alkaloids
Pilocarpine
Prominent muscarinic actions. causes marked sweating. salivation. Increase of secretions. small doses cause fall in BP but higher doses increase in BP. Applied to the eye cause miosis. fall in intraocular tension

Uses
I. .Open angle glaucoma
2. To counteract mydriasis

Anticholinesterase
They inhibit the enzyme cholinestrase and prolong the action of Ach

Reversible 
Physostigamine, Ncostigamine, Pyridostigamine, Ambenonium, Edrophonium, Demecarium

Irreverible
Dyflos. Echothiphate.

Pharmacological Actions
I Ganglia - persistent depolarisation of ganglionic nicotinic receptors.
2 CVS - unprcdictable as Muscarinic-I receptor causes bradycardia but ganglionic stimulation
tachycardia.
3. Skeletal muscles - as Ach is not destroyed and rebinds to the same receptor or it diffuses on to the neighbouring receptors to cause repetitive firing. twitching and fasciculations.

Uses 
I As miotic
a) Glaucoma :  Acute congestive (narrow angle) glaucoma,  Chronic simple (wide angle)  glaucoma
b) Counter act  atropine mydriasis.
2) Post operative paralytic ileus
3) Myasthenia gravis
4) Postoperativedecurarization
5) Cobra bite
6) Belladona poisoning
7) Other drug overdoses

Meperidine (Demerol)

Meperidine is a phenylpiperidine and has a number of congeners. It is mostly effective in the CNS and bowel

• Produces analgesia, sedation, euphoria and respiratory depression.
• Less potent than morphine, 80-100 mg meperidine equals 10 mg morphine.
• Shorter duration of action than morphine (2-4 hrs).
• Meperidine has greater excitatory activity than does morphine and toxicity may lead to convulsions.
• Meperidine appears to have some atropine-like activity.
• Does not constrict the pupils to the same extent as morphine.
• Does not cause as much constipation as morphine.
• Spasmogenic effect on GI and biliary tract smooth muscle is less pronounced than that produced by morphine.
• Not an effective antitussive agent.
• In contrast to morphine, meperidine increases the force of oxytocin-induced contractions of the uterus.
• Often the drug of choice during delivery due to its lack of inhibitory effect on uterine contractions and its relatively short duration of action.
• It has serotonergic activity when combined with monoamine oxidase inhibitors, which can produce serotonin toxicity (clonus, hyperreflexia, hyperthermia, and agitation)

Serotonin-norepinephrine reuptake inhibitors(SNRIs)

e.g. venlafaxine and duloxetine
- Inhibit the reuptake of both 5-HT and norepinephrine 
- Has a more favourable adverse effect profile than TCAs

Norepinephrine reuptake inhibitor

e.g. bupropion, reboxetine

Monoamine receptor antagonists

e.g. mirtazapine, trazodone, mianserin

PHARMACOLOGY OF LOCAL ANESTHETICS

 Characteristics

1. Block axon conduction (nerve impulse) when applied locally in appropriate concentrations.

2. Local anesthetic action must be completely reversible; however, the duration of the anesthetic block should be of sufficient length to allow completion of the planned treatment.

3. Produce minimal local toxic effects such as nerve and muscle damage as well as minimal systemic toxic effects of organ systems such as the cardiovascular and central nervous system.

Histamine: 

Involved in inflammatory and anaphylactic reactions 
Local application causes swelling redness, and edema, mimicking a mild inflammatory reaction.

Large systemic doses leads to profound vascular changes similar to those seen after shock or anaphylactic origin.

Storage: widely distributed; in tissues, primarily in mast cells; in blood- in basophils, platelets; non-mast cell sites (epidermis, CNS, regenerating cells)

Histamine Stored in complex with:
Heparin
Chondroitin Sulfate
Eosinophilic Chemotactic Factor
Neutrophilic Chemotactic Factor
Proteases

Release: during type I (IgE-mediated) immediate hypersensitivity rxns, tissue injury, in response to some drugs
a.    Process: Fcε receptor on mast cell or basophil binds IgE, when Ag binds → ↑ PLC activity → histamine

Symptoms: bronchoconstriction, ↓ Pa, ↑ capillary permeability, edema

Action

H1 receptors are located mainly on smooth muscle cells in blood vessels and the respiratory and GI tracts. When histamine binds with these receptors producing the following effects.

-Contraction of smooth muscle in the bronchi and bronchioles producing bronchoconstraction.

-stimulation of vagus nerve endings to produce reflex bronchoconstraction and cough.

-Increased permeability of veins and capillaries, which allows fluid to flow into subcutaneous tissues and form edema (little lower blood pressure).

-Increased secretion of mucous glands. Mucosal edema and increased nasal mucus produce the nasal congestion characteristic of allergic rhinitis and the common cold.

-Stimulation of sensory peripheral nerve endings to cause pain and pruritus.

Histamine promotes vasodilation by causing vascular endothelium to release nitric oxide. This chemical signal diffuses to the vascular smooth muscle, where it stimulates cyclic guanosine monophosphate production, causing vasodilation.

H2-receptors present mostly in gastric glands and smooth muscle of some blood vessels. When receptors are stimulated, the main effects are increased secretion of gastric acid and pepsin, increased rate and force of myocardial contraction.

The H3-receptor functions as a negative-feedback mechanism to inhibit histamine synthesis and release in many body tissues. Stimulation of H3 receptors opposes the effects produced by stimulation of H1 receptors.

The H4- receptor is expressed in only a few cell types, and their role in drug action is unclear.

Drugs cause release of histamine: 

Many drugs can cause release of histamine in the body.
-Intracutaneouse morphine injection in humans produced localized redness, localized edema and a diffuse redness. This is due to release of histamine.

-I.V. inj of curare may cause bronchial constriction due to release of histamine.

-codeine , papaverine, meperidine (pethedine), atropine, hydralizine and sympathomimetic amines, histamine releases by these drugs may not be significant unless they are administered I.V in large doses

Pharmacological effects

-  If injected I.V. (0.1 mg of histamine) causes a sharp decline in the blood pressure, flushing of the face and headache. 
- There is also stimulation of gastric acid secretion. 
- If this injection is given to an asthmatic individual, there will be a marked decrease in vital capacity and a sever attack of asthma. 

Circulatory effects of histamine:

The two factors involved in the circulatory action of histamine are:
Arteriolar dilatation and
Capillary permeability
So it leads to loss of plasma from circulation

Effect on gastric secretion:
Histamine is a potent stimulant of gastric Hcl secretion.